phenyl-n-tert-butylnitrone has been researched along with Degenerative Diseases, Central Nervous System in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro, A; Cerecetto, H; Ferreira, A; González, M; Hernández, P; Olea-Azar, C; Porcal, W | 1 |
| Castro Faria Neto, HC; Floyd, RA; Hensley, K; Towner, RA; Zimmerman, GA | 1 |
| Aschner, M; Gupta, RC; Milatovic, D; Zaja-Milatovic, S | 1 |
| Floyd, RA; Hensley, K; Jaffery, F; Maidt, L; Pye, Q; Robinson, K; Stewart, C | 1 |
| Floyd, RA | 1 |
| Cantuti-Castelvetri, I; Kelicen, P; Paulson, KE; Pekiner, C | 1 |
2 review(s) available for phenyl-n-tert-butylnitrone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.
Topics: Alanine; Antineoplastic Agents; Benzenesulfonates; Cyclic N-Oxides; Drug Combinations; Free Radicals; Humans; Imines; Neoplasms; Neurodegenerative Diseases; Sulfides | 2013 |
Antioxidants, oxidative stress, and degenerative neurological disorders.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Cyclic N-Oxides; Free Radicals; Humans; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Vitamin E | 1999 |
4 other study(ies) available for phenyl-n-tert-butylnitrone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
Topics: Animals; Binding Sites; Cell Survival; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Heterocyclic Compounds; Humans; Hydrogen Peroxide; Macrophages; Mice; Molecular Structure; Neurodegenerative Diseases; Neuroprotective Agents; Reactive Oxygen Species; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2008 |
Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.
Topics: Animals; Antioxidants; Biomarkers; Brain; Cholinesterase Inhibitors; Cyclic N-Oxides; Disease Models, Animal; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Isoflurophate; Lipid Peroxidation; Male; Memantine; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Time Factors; Vitamin A | 2009 |
Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps.
Topics: Acquired Immunodeficiency Syndrome; Animals; Animals, Newborn; Blotting, Western; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Cytokines; Electrophysiology; Free Radical Scavengers; HIV Envelope Protein gp120; Immunohistochemistry; Inflammation; Neurodegenerative Diseases; Neuroglia; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ribonucleases; Spin Labels | 1999 |
The spin trapping agent PBN stimulates H2 O2 -induced Erk and Src kinase activity in human neuroblastoma cells.
Topics: Calcium; Calcium Channels, L-Type; Central Nervous System; Cyclic N-Oxides; Drug Interactions; Epidermal Growth Factor; Extracellular Space; Humans; Hydrogen Peroxide; Membrane Potentials; Mitogen-Activated Protein Kinases; Neuroblastoma; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Potassium Chloride; src-Family Kinases; Tumor Cells, Cultured | 2002 |